Effect of pronase on high-incidence blood group antigens and the prevalence of antibodies to pronase-treated erythrocytes

Immunohematology

Volumn 12, Issue 4, 1996, Pages 139-142

  Reid, M E ^a   Green, C A ^b   Hoffer, J ^c   Oyen R ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Immunohematology Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; CELL MEMBRANE PROTEIN; ERYTHROCYTE ANTIBODY; PRONASE; PROTEINASE;

ARTICLE; BLOOD GROUP LUTHERAN SYSTEM; BLOOD GROUP SYSTEM; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; PREVALENCE; PRIORITY JOURNAL; SERUM;

EID: 0030449598     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Daniels G. Effect of enzymes on and chemical modifications of high-frequency red cell antigens. Immunohematology 1992;8:53-7.
2. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. Oxford, England: Blackwell Scientific Publications, 1993:318.
3. Prager MD, Soules ML, Fletcher MA. Further studies on the mechanism of the effect of enzymes on erythrocyte serology with special reference to pronase. Transfusion 1968;8:220-5.
4. Judson PA, Anstee DJ. Comparative effect of trypsin and chymotrypsin on blood group antigens. Med Lab Sci 1977;34:1-6.
5. Parsons SF, Spring FA, Merry AH, et al. Evidence that Cromer-related blood group antigens are carried on decay accelerating factor (DAF) suggests that the Inab phenotype is a novel form of DAF deficiency (abstract). Proceedings of the XXth Congress of the International Society of Blood Transfusion, Manchester, British Blood Transfusion Society,1988:116.
6. Telen MJ, Hall SE, Green AM, Moulds JJ, Rosse WF. Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med 1988;167:1993-8.
7. Petty AC, Daniels GL, Anstee DJ, Tippett P. Use of the MAIEA technique to confirm the relationship between the Cromer antigens and decay-accelerating factor and to assign provisionally antigens to the short-consensus repeats. Vox Sang 1993;65:309-15.
8. Lublin DM, Mallinson G, Poole J, et al. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 1994;84:1276-82.
9. a epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 1994;84:3205-11.
10. b on decay-accelerating factor (letter). Transfusion 1995;35:278.
11. Spring FA, Judson PA, Daniels GL, Parsons SF, Mallinson G, Anstee DJ. A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets. Immunology 1987:62:307-13.
12. a/Hy-active glycoprotein. Vox Sang 1994;66:72-7.
13. a antigens belong to the Dombrock blood group system. Vox Sang 1995;68:177-82.
14. r 60,000 expresses the Sc1 and Sc2 antigens. Vox Sang 1990;58:122-5.
15. Spring FA. Characterization of blood-group-active erythrocyte membrane glycoproteins with human antisera. Transfus Med 1993;3:167-78.
16. b antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 1995;90:823-9.
17. 854→Leu. J Biol Chem 1994;269:16155-8.
18. Bruce LJ, Ring SM, Anstee DJ, Reid ME, Wilkinson S, Tanner MJA. Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte band 3: a site of interaction between band 3 and glycophorin A under certain conditions. Blood 1995;85:541-7.
19. Smythe JS, Spring FA, Gardner B, Parsons SF, Judson PA, Anstee DJ. Monoclonal antibodies recognizing epitopes on the extracellular face and intracellular N-terminus of the human erythrocyte anion transporter (band 3) and their application to the analysis of South East Asian ovalocytes. Blood 1995;85:2929-36.
20. ab from anti-D. Med Lab Sci 1985;42:88-9.